Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
10.86
-0.01 (-0.09%)
At close: Feb 12, 2026, 4:00 PM EST
10.72
-0.14 (-1.29%)
Pre-market: Feb 13, 2026, 4:50 AM EST
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $716.44 million as of February 13, 2026. Its market cap has increased by 227.96% in one year.
Market Cap
716.44M
Enterprise Value
522.80M
1-Year Change
227.96%
Ranking
Category
Stock Price
$10.86
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $716.44M, an increase of 137.51%. That is a compound annual growth rate of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 717.10M | -3.89% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KalVista Pharmaceuticals | 763.50M |
| AgomAb Therapeutics NV | 763.22M |
| Arvinas | 760.09M |
| MiMedx Group | 753.84M |
| MapLight Therapeutics | 751.51M |
| Gyre Therapeutics | 710.76M |
| Kura Oncology | 697.88M |
| Upstream Bio | 691.69M |